Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2007
06/21/2007CA2628952A1 Aspartic protease inhibitors
06/20/2007EP1798233A1 Pyrrolo[1,2-a]quinoxaline derivatives as Adenosine A3 receptor modulators and uses thereof
06/20/2007EP1798230A1 Substituted alkylamine derivatives and methods of use
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound
06/20/2007EP1797898A1 Preventive/therapeutic drug for arteriosclerosis
06/20/2007EP1797893A2 New composition
06/20/2007EP1797881A1 Medicinal composition
06/20/2007EP1797878A2 Benzothiazole derivatives
06/20/2007EP1797877A1 Joint use of sulfonamide based compound with angiogenesis inhibitor
06/20/2007EP1797099A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
06/20/2007EP1797079A1 Proline derivatives
06/20/2007EP1797078A1 Compounds, compositions containing them, preparation thereof and uses thereof iii
06/20/2007EP1797077A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
06/20/2007EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/20/2007EP1797075A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands
06/20/2007EP1797071A1 Carbonyl compounds usable as coagulation factor xa inhibitors
06/20/2007EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/20/2007EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
06/20/2007EP1796685A1 Pyridoxal-5´-phosphate and related compounds in combination with therapeutic cadiovascular compounds for treating angina.
06/20/2007EP1796666A1 Methods and compositions for the treatment of hyperlipidemia
06/20/2007EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/20/2007EP1796655A2 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases
06/20/2007EP1796480A1 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
06/20/2007EP1599452B1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors
06/20/2007EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier
06/20/2007EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1379254B1 Use of bile acid or bile salt fatty acid conjugates
06/20/2007EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression
06/20/2007EP1324760B1 Creatine ester pronutrient compounds and formulations
06/20/2007EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
06/20/2007EP1158989B1 Use of inhibitors of endotoxin for the treatment of cachexia
06/20/2007EP1012329B1 Diagnosis and treatment of myocardial failure
06/20/2007EP0789593B1 Yeast-based delivery vehicles
06/20/2007CN1985002A GM3 synthase as a therapeutic target in microvascular complications of diabetes
06/20/2007CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
06/20/2007CN1984905A Constrained himbacine analogs as thrombin receptor antagonists
06/20/2007CN1984647A Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
06/20/2007CN1982457A Toxic sequential, its preparation and use
06/20/2007CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/20/2007CN1981887A Therapeutic use of growth factor, and delivery device, especially for the treatment of intima hyperplasia
06/20/2007CN1981861A Yixinkang preparation for treating cardiovascular and cerebrovascular diseases and its quality controlling method
06/20/2007CN1981857A Medicinal composition of milkvetch root, chinaroot greenbrier and Hong Jingtian and its making method
06/20/2007CN1981853A Chinese-medicinal decoction for treating heart disease and cerebral thrombosis and its making method
06/20/2007CN1981849A Production and use for milkvetch root Shengmai injection
06/20/2007CN1981848A Extraction and use for cold-pressed concentrate composition of celery, Chinese onion and onion
06/20/2007CN1981836A Stasis-expelling drop pills for treating coronary heart disease, angina cordis and high blood fat and thereof making method
06/20/2007CN1981822A Tree-peony root bark effective component, its preparation, making method and use
06/20/2007CN1981821A Tree-peony root bark effective component, its preparation, making method and use
06/20/2007CN1981820A Tree-peony root bark effective component, its preparation, making method and use
06/20/2007CN1981819A Tree-peony root bark component, its preparation, making method and use
06/20/2007CN1981818A Chinese-medicinal composition, preparation and use for treating cardiovascular diseases
06/20/2007CN1981817A Chinese-medicinal composition for treating cardiovascular diseases, its preparation and use
06/20/2007CN1981816A Chinese-medicinal composition for treating ischemic heart disease, its preparation and use
06/20/2007CN1981811A Danshen effective component, its preparation, making method and usage
06/20/2007CN1981810A Danshen component, preparation, making method and usage
06/20/2007CN1981809A Danshen effective component, its preparation, making method and usage
06/20/2007CN1981805A Danshen root and Sanchi effective-component composition, its production and use
06/20/2007CN1981803A Chinese-medicinal composition for preventing cardiovascular diseases and its production
06/20/2007CN1981802A Chinese-medicinal preparation for treating cardiovascular diseases, its production and use
06/20/2007CN1981801A Chinese-medicinal preparation for treating cardiovascular diseases, its production and use
06/20/2007CN1981800A Chinese-medicinal preparation for treating cardiovascular diseases, its production and use
06/20/2007CN1981790A Rhizoma Chuanxiong effective components and production thereof
06/20/2007CN1981789A Seabuckthorn flavonid micropills and their production
06/20/2007CN1981781A Bear-ball total bound cholic acid injection, its production and usage
06/20/2007CN1981777A Chinese medicinal preparation for treating cardio vascular diseases, its making method and use
06/20/2007CN1981776A Composition containing rare ginseng saponin, its production and usage
06/20/2007CN1981774A Medicinal compositions
06/20/2007CN1981772A Composition and method for decreasing concentration of low density lipoprotein cholesterol
06/20/2007CN1981768A Compound benazepril dropping balls and their production
06/20/2007CN1981767A Benazepril hydrochloride dropping balls and their production
06/20/2007CN1981766A Losartan potassium and hydrochrothiazide dropping pills and their preparing methods
06/20/2007CN1981762A Medicinal composition for treating pneumonitis and cardiovascular diseases and its making method
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/20/2007CN1981759A Levamlodipine besylate dropping balls and their making method
06/20/2007CN1981758A Losartan polassium dropping pills and their preparation
06/20/2007CN1981757A Perindopril dropping balls and their preparation
06/20/2007CN1981756A Fosinopril sodium dropping balls and their making method
06/20/2007CN1981752A Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
06/20/2007CN1981750A Soluble A-SH CoA-SH Q10 composition and its production
06/20/2007CN1981739A Esmolol preparation
06/20/2007CN1981623A Coarse-cereals gruel for preventing from arteriosclerosis
06/20/2007CN1322126C Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
06/20/2007CN1322001C Novel compounds that inhibit factor Xa activity
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
06/20/2007CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
06/20/2007CN1321679C Ginger and dried orange peel extracts mixture for treating cardiovascular disease
06/20/2007CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities
06/20/2007CN1321664C Chinese medicinal formulation for treating asthma and cough
06/20/2007CN1321651C Oral cavity spray containing two effective parts of compound red sage root formula and its preparation process
06/20/2007CN1321650C Effervescent tables for treating thrombus, and its prepn. method
06/20/2007CN1321645C Oral effervesce tablets for treating cardiovascular and cerebrovascular diseases, and prepn. method therefor
06/20/2007CN1321644C Process for making substituted pyrazoles
06/20/2007CN1321638C Ligustilide oil and its preparation
06/20/2007CN1321635C Binding partners for 5-HT5 receptors for treatment of migraine
06/19/2007US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 1595